Abstract

There are genetic and environmental risk factors that contribute to the development of cognitive decline in Alzheimer’s disease (AD). Some of these include the genetic predisposition of the apolipoprotein E4 genotype, consuming a high-fat diet (HFD), and the female sex. Brain insulin receptor resistance and deficiency have also been shown to be associated with AD and cognitive impairment. Intranasal (INL) insulin enhances cognition in AD, but the response varies due to genotype, diet, and sex. We investigated here the combination of these risk factors in a humanized mouse model, expressing E3 or E4, following a HFD in males and females on cognitive performance and the brain distribution of insulin following INL delivery. The HFD had a negative effect on survival in male mice only, requiring sex to be collapsed. We found many genotype, diet, and genotype x diet effects in anxiety-related tasks. We further found beneficial effects of INL insulin in our memory tests, with the most important findings showing a beneficial effect of INL insulin in mice on a HFD. We found insulin distribution throughout the brain after INL delivery was largely unaffected by diet and genotype, indicating these susceptible groups can still receive adequate levels of insulin following INL delivery. Our findings support the involvement of brain insulin signaling in cognition and highlight continuing efforts investigating mechanisms resulting from treatment with INL insulin.

Details

Title
Effects of a high-fat diet on cognition and brain distribution of intranasal insulin in E3 and E4 male and female mice
Author
Chaklai, Ariel 1 ; Rhea, Elizabeth M. 2 ; O’Niel, Abigail 1 ; Babin, Alice 3 ; Weaver, Riley 3 ; Pemberton, Sarah 3 ; Banks, William A. 2   VIAFID ORCID Logo  ; Raber, Jacob 4 

 Oregon Health & Science University, Department of Behavioral Neuroscience, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690) 
 Veterans Affairs Puget Sound Health Care System, Geriatric Research Education and Clinical Center, Seattle, USA (GRID:grid.511190.d) (ISNI:0000 0004 7648 112X); University of Washington, Department of Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000 0001 2298 6657) 
 Veterans Affairs Puget Sound Health Care System, Geriatric Research Education and Clinical Center, Seattle, USA (GRID:grid.511190.d) (ISNI:0000 0004 7648 112X) 
 Oregon Health & Science University, Department of Behavioral Neuroscience, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690); ONPRC, Oregon Health & Science University, Division of Neuroscience, Departments of Neurology and Radiation Medicine, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690) 
Pages
18641
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3091435371
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.